This inventor holds 1 USPTO granted patent. Top assignee: Centre International De Recherches Dermatologiques. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Christian Frelin: Innovator in Retinoid Research
Introduction
Christian Frelin is a notable inventor based in Nice, France. He has made significant contributions to the field of dermatological research, particularly in the area of retinoid therapy. His work focuses on the inhibition of vascular endothelial growth factor (VEGF), which plays a crucial role in various disease states.
Latest Patents
Christian Frelin holds a patent for "Retinoid inhibition of expression of VEGF." This innovative approach utilizes retinoids, specifically anti-AP-1 retinoids, to effectively inhibit the expression of VEGF. This discovery is particularly valuable for therapeutic treatments aimed at conditions characterized by an overexpression of VEGF.
Career Highlights
Frelin is associated with the Centre International de Recherches Dermatologiques, where he conducts his research. His work has garnered attention for its potential applications in treating skin-related diseases and conditions.
Collaborations
Christian collaborates with esteemed colleagues, including Barbara Vega and Annie Ladoux. Their combined expertise enhances the research efforts at the Centre International de Recherches Dermatologiques.
Conclusion
Christian Frelin's innovative research in retinoid therapy represents a significant advancement in dermatological treatments. His patent on VEGF inhibition showcases the potential for new therapeutic strategies in managing diseases associated with this growth factor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile